Offer - Urjas Oil for just ₹ 1 X
Omifin-Plus is an allopathic medicine The correct dosage of Omifin-Plus depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Omifin-Plus is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Omifin-Plus safe for pregnant women?
It is not known what effect Omifin-Plus will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Omifin-Plus safe during breastfeeding?
No research work has been carried out till date on effect of Omifin-Plus on breastfeeding women. So it is not known whether taking Omifin-Plus will cause side effects or not.
What is the effect of Omifin-Plus on the Kidneys?
No research work has been carried out till date on effects of Omifin-Plus on kidney. So it is not known whether taking Omifin-Plus will cause side effects on kidney or not.
What is the effect of Omifin-Plus on the Liver?
Information about safety of Omifin-Plus for the liver is not available since scientific research on this is yet to be done.
What is the effect of Omifin-Plus on the Heart?
In the absence of any scientific study on the side effects of Omifin-Plus on the heart, information on safety of Omifin-Plus for the heart is unavailable.
Omifin-Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Omifin-Plus unless your doctor advises you to do so -
Is this Omifin-Plus habit forming or addictive?
Omifin-Plus is not addictive in nature.
Interaction between Food and Omifin-Plus
Information is not available on the interaction of any foods with Omifin-Plus, due to a lack of research on this.
Interaction between Alcohol and Omifin-Plus
No research has been done on this till date. Therefore, it is not known what the effect of taking Omifin-Plus with alcohol will be.
Yes, long-term use of Omifin-Plus can increase the risk of tendonitis and tendon rupture in some people. However, the exact mechanism of tendon rupture is not known. If you suffer from tendon rupture or any kind of muscular pain after consuming this drug, please consult your doctor immediately.
Omifin-Plus is a brand name of ofloxacin. It is a prescription drug that belongs to the class of medication called fluoroquinolones. It is a broad spectrum antibiotic, used for treating bacterial infections, such as bronchitis, pneumonia, urinary, respiratory, skin, gastrointestinal, anthrax, bone, and eye infections.
Yes Omifin-Plus is used to treat typhoid fever. If other antibiotics are resistance to salmonella typhi then it is very effective to treat typhoid fever. however, it is best to consult your doctor about the right treatment for typhoid fever.
Yes, Omifin-Plus is safe to use, if taken in the prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as stomach pain, nausea, diarrhea, headache, difficulty in breathing, and constipation.
Discontinuing Omifin-Plus on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sporanox ® (itraconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 794-795